Search

Thanh Lam

Examiner (ID: 3594, Phone: (571)272-2026 , Office: P/2834 )

Most Active Art Unit
2834
Art Unit(s)
2834, 2832
Total Applications
2494
Issued Applications
2201
Pending Applications
50
Abandoned Applications
243

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10892913 [patent_doc_number] => 08916525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'TNF-A and TWEAK dual antagonist for the prophylaxis and treatment of autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 13/635868 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 15182 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635868 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/635868
TNF-A and TWEAK dual antagonist for the prophylaxis and treatment of autoimmune diseases Mar 17, 2011 Issued
Array ( [id] => 10169357 [patent_doc_number] => 09200058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Dual antagonist for TNF-α and IL-21 for preventing and treating autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 13/635874 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 13681 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635874 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/635874
Dual antagonist for TNF-α and IL-21 for preventing and treating autoimmune diseases Mar 17, 2011 Issued
Array ( [id] => 8755255 [patent_doc_number] => 20130089560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'BONE MORPHOGENETIC PROTEIN RECEPTOR BINDING AGENTS AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/635116 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31875 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635116 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/635116
BONE MORPHOGENETIC PROTEIN RECEPTOR BINDING AGENTS AND METHODS OF THEIR USE Mar 16, 2011 Abandoned
Array ( [id] => 10887743 [patent_doc_number] => 08911736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Combination therapy for treating breast cancer' [patent_app_type] => utility [patent_app_number] => 13/634392 [patent_app_country] => US [patent_app_date] => 2011-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16166 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634392 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/634392
Combination therapy for treating breast cancer Mar 7, 2011 Issued
Array ( [id] => 10046024 [patent_doc_number] => 09086418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Methods and compositions for diagnosing ankylosing spondylitis using biomarkers' [patent_app_type] => utility [patent_app_number] => 13/034809 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27770 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13034809 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/034809
Methods and compositions for diagnosing ankylosing spondylitis using biomarkers Feb 24, 2011 Issued
Array ( [id] => 10586681 [patent_doc_number] => 09308277 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage' [patent_app_type] => utility [patent_app_number] => 13/029891 [patent_app_country] => US [patent_app_date] => 2011-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18448 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13029891 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/029891
Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage Feb 16, 2011 Issued
Array ( [id] => 6080086 [patent_doc_number] => 20110142832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/021545 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11275 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142832.pdf [firstpage_image] =>[orig_patent_app_number] => 13021545 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/021545
Soluble tumor necrosis factor receptor treatment of medical disorders Feb 3, 2011 Issued
Array ( [id] => 8648833 [patent_doc_number] => 20130034563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'USE FOR PRODUCTION OF THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR OSTEOARTHRITIS' [patent_app_type] => utility [patent_app_number] => 13/575632 [patent_app_country] => US [patent_app_date] => 2011-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17088 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575632 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/575632
USE FOR PRODUCTION OF THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR OSTEOARTHRITIS Jan 26, 2011 Abandoned
Array ( [id] => 8606094 [patent_doc_number] => 20130011407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF OSTEOARTHRITIS, AND METHOD OF PRODUCTION THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/575650 [patent_app_country] => US [patent_app_date] => 2011-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17078 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575650 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/575650
PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF OSTEOARTHRITIS, AND METHOD OF PRODUCTION THEREFOR Jan 26, 2011 Abandoned
Array ( [id] => 8606104 [patent_doc_number] => 20130011416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'INJECTABLE SOLUTION CONTAINING THERAPEUTIC AGENT FOR OSTEOARTHRITIS' [patent_app_type] => utility [patent_app_number] => 13/575620 [patent_app_country] => US [patent_app_date] => 2011-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17291 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575620 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/575620
Injectable solution containing therapeutic agent for osteoarthritis Jan 26, 2011 Issued
Array ( [id] => 6001733 [patent_doc_number] => 20110117584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Detection of Chronic Kidney Disease Patients or Coronary Artery Disease Using Bone Morphogenic Protein-4' [patent_app_type] => utility [patent_app_number] => 13/009428 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3465 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117584.pdf [firstpage_image] =>[orig_patent_app_number] => 13009428 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/009428
Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4 Jan 18, 2011 Issued
Array ( [id] => 5958519 [patent_doc_number] => 20110182906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'FULLY HUMAN ANTIBODY TO HUMAN TNF-ALPHA, MOLECULAR EVOLUTION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/008015 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6354 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182906.pdf [firstpage_image] =>[orig_patent_app_number] => 13008015 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/008015
Fully human antibody to human TNFα, molecular evolution and use thereof Jan 17, 2011 Issued
Array ( [id] => 6187841 [patent_doc_number] => 20110171228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins' [patent_app_type] => utility [patent_app_number] => 13/008566 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28831 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171228.pdf [firstpage_image] =>[orig_patent_app_number] => 13008566 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/008566
Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins Jan 17, 2011 Abandoned
Array ( [id] => 6187845 [patent_doc_number] => 20110171231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'ANTI-PlGF ANTIBODIES AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 13/005067 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 35939 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171231.pdf [firstpage_image] =>[orig_patent_app_number] => 13005067 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/005067
ANTI-PlGF ANTIBODIES AND METHODS USING SAME Jan 11, 2011 Abandoned
Array ( [id] => 5943493 [patent_doc_number] => 20110104113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE' [patent_app_type] => utility [patent_app_number] => 12/987016 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9897 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104113.pdf [firstpage_image] =>[orig_patent_app_number] => 12987016 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/987016
Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device Jan 6, 2011 Issued
Array ( [id] => 6111511 [patent_doc_number] => 20110189769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR MANIPULATING THE GUIDED NAVIGATION OF ENDOTHELIAL TUBES DURING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/975160 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6071 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189769.pdf [firstpage_image] =>[orig_patent_app_number] => 12975160 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/975160
METHODS AND COMPOSITIONS FOR MANIPULATING THE GUIDED NAVIGATION OF ENDOTHELIAL TUBES DURING ANGIOGENESIS Dec 20, 2010 Abandoned
Array ( [id] => 9762293 [patent_doc_number] => 08846616 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-09-30 [patent_title] => 'Alpha-melanocyte stimulating hormone as topical anti-inflammatory agent for the treatment of allergic contact dermatitis and eczema' [patent_app_type] => utility [patent_app_number] => 12/942369 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7830 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12942369 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/942369
Alpha-melanocyte stimulating hormone as topical anti-inflammatory agent for the treatment of allergic contact dermatitis and eczema Nov 8, 2010 Issued
Array ( [id] => 8796657 [patent_doc_number] => 08435525 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-05-07 [patent_title] => 'FGF modulation of in vivo antibody production and humoral immunity' [patent_app_type] => utility [patent_app_number] => 12/941070 [patent_app_country] => US [patent_app_date] => 2010-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 10477 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12941070 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/941070
FGF modulation of in vivo antibody production and humoral immunity Nov 6, 2010 Issued
Array ( [id] => 6142186 [patent_doc_number] => 20110129469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'METHODS FOR TREATING FATTY LIVER DISEASE' [patent_app_type] => utility [patent_app_number] => 12/939084 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19070 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129469.pdf [firstpage_image] =>[orig_patent_app_number] => 12939084 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/939084
METHODS FOR TREATING FATTY LIVER DISEASE Nov 2, 2010 Abandoned
Array ( [id] => 6084467 [patent_doc_number] => 20110144205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Blood Glutathione as a Biomarker for Screening Asymptomatic Patients at Risk for Heart Failure' [patent_app_type] => utility [patent_app_number] => 12/908163 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10096 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144205.pdf [firstpage_image] =>[orig_patent_app_number] => 12908163 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/908163
Blood Glutathione as a Biomarker for Screening Asymptomatic Patients at Risk for Heart Failure Oct 19, 2010 Abandoned
Menu